ODDB.org: Open Drug Database

Swissmedic Registration	69722	Date of registration	27.03.2025
Company name	Novartis Pharma Schweiz AG	Revision date
		Valid until	26.03.2030
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Jakavi 5 mg/ml	Lösung zum Einnehmen	Solution (oral) (Ruxolitinibum 5 mg/ml)	L01EJ01

2025	©ywesee GmbH